NCCN task force report: Management of neuropathy in cancer

Michael D. Stubblefield, Harold J. Burstein, Allen W. Burton, Christian M. Custodio, Gary E. Deng, Maria Ho, Larry Junck, G. Stephen Morris, Judith A. Paice, Sudhakar Tummala, Jamie H. Von Roenn

Research output: Contribution to journalReview article

156 Scopus citations

Abstract

Neuropathy is a common, often debilitating complication of cancer and its treatment. Effective management of this disorder depends on early diagnosis and an understanding of its underlying causes in the individual patient. In January 2009, NCCN gathered a multidisciplinary group to review the literature and discuss intervention strategies currently available to patients as well as areas that require research efforts. The task force, which comprised experts in anesthesiology, medical oncology, neurology, neuro-oncology, neurophysiology, nursing, pain management, and rehabilitation, was charged with the goal of outlining recommendations for the possible prevention, diagnosis, and management of neuropathy. This report documents the proceedings of this meeting with a general background on neuropathy and neuropathy in oncology, followed by discussions on challenges and research issues, evaluation criteria, and management of different symptoms associated with this disorder.

Original languageEnglish (US)
Pages (from-to)S1-S26
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue numberSUPPL. 5
StatePublished - 2009

Keywords

  • Cancer treatment
  • NCCN task force
  • Neuropathy

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN task force report: Management of neuropathy in cancer'. Together they form a unique fingerprint.

  • Cite this

    Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., Junck, L., Morris, G. S., Paice, J. A., Tummala, S., & Von Roenn, J. H. (2009). NCCN task force report: Management of neuropathy in cancer. JNCCN Journal of the National Comprehensive Cancer Network, 7(SUPPL. 5), S1-S26.